GEM - PHARM, spol. s r.o.
Basic details
- Company ID (IČO)
- 36598607
- Tax ID (DIČ)
- 2022071667
- VAT ID (IČ DPH)
- SK2022071667
- VAT
- Registered for VAT under §4 since 1/12/2005
- Registered office
- Albinovská 644/14, 07801 Sečovce
- District
- Trebišov (SK042B)
- Legal form
- Spoločnosť s ručením obmedzeným
- Register entry
- Obchodný register Mestského súdu Košice, oddiel Sro, vložka 17180/V
- Main activity (SK NACE)
- 47.73 · Maloobchod s farmaceutickými výrobkami
- Employees
- 3-4 zamestnanci
- Established
- 13/10/2005
Commercial register
Data updated: 25/10/2026, 09:22 (26 days ago)
- Registered capital
- €6,640 (paid up €6,640)
- Acting for the company
- Spoločnosť zastupuje a písomnosti zakladajúce práva a povinnosti spoločnosti podpisuje konateľ samostatne a to tak, že k písanému alebo tlačenému obchodnému menu spoločnosti pripojí svoj vlastnoručný podpis.
Shareholders
- Mgr. Michaela Gajdoščíkováfrom 7/8/2021
- Mgr. Monika Kandrákováfrom 7/8/2021
Statutory body
- Mgr. Michaela Gajdoščíkováfrom 26/7/2021
- Mgr. Monika Kandrákováfrom 13/10/2005
This is a copy from the Register of Legal Entities, not a court extract for legal acts. Look up on orsr.sk
Peppol
We found no entry for its tax ID in the OpenPeppol Directory. Listing in the directory is voluntary, so this does not mean the company does not use Peppol.
Bank accounts

SK49 0200 0000 0043 3798 8251
Accounts the Slovak Financial Administration publishes for VAT payers.
Connections
GEM - PHARM, spol. s r.o.
FinPOST.sk
Financial data
No selected figures are published for this company or year.
FinPOST.sk
Financial data
From the financial statements in the Register of Financial Statements (RÚZ), in euros, for the last 5 years (each column is one fiscal year). Not verified; shown as the company filed them.
In 2021, GEM - PHARM, spol. s r.o. decreased its revenue by 9% to €424,074 and its profit rose by 379% to €1,677. Equity rose by 5% to €38,394 and the debt ratio rose to 71.65%.
In 2022, GEM - PHARM, spol. s r.o. increased its revenue by 19% to €506,738 and its profit rose by 8% to €1,803. Equity rose by 5% to €40,198 and the debt ratio fell to 71.43%.
In 2023, GEM - PHARM, spol. s r.o. decreased its revenue by 8% to €466,469 and its profit fell by 6% to €1,702. Equity rose by 4% to €41,900 and the debt ratio fell to 71.29%.
In 2024, GEM - PHARM, spol. s r.o. increased its revenue by 3% to €480,623 and its profit rose by 211% to €5,287. Equity rose by 13% to €47,219 and the debt ratio fell to 64.67%.
In 2025, GEM - PHARM, spol. s r.o. decreased its revenue by 3% to €465,647 and made a loss of €2,438. Equity fell by 6% to €44,283 and the debt ratio rose to 67.41%.
Revenue
GEM - PHARM, spol. s r.o.
| Year | Revenue |
|---|---|
| 2021 | €424,074 |
| 2022 | €506,738 |
| 2023 | €466,469 |
| 2024 | €480,623 |
| 2025 | €465,647 |
Profit
GEM - PHARM, spol. s r.o.
| Year | Profit |
|---|---|
| 2021 | €1,677 |
| 2022 | €1,803 |
| 2023 | €1,702 |
| 2024 | €5,287 |
| 2025 | −€2,438 |
- Revenue
- €424,074
- Profit
- €1,677
- Assets
- €135,412
- Equity and liabilities
- €135,412
- Equity
- €38,394
- Debt ratio What it shows: How much of its assets the company finances with borrowed funds.
How it is computed: (Liabilities + Accruals) / Assets - 71.65%
- Gross margin What it shows: The share of revenue left after the cost of goods, materials, energy and services.
How it is computed: Value added / Revenue - 8.46%
Financial statements as PDF
The files open in the Register of Financial Statements (RÚZ) in a new tab.
- Revenue
- €506,738
- Profit
- €1,803
- Assets
- €140,714
- Equity and liabilities
- €140,714
- Equity
- €40,198
- Debt ratio What it shows: How much of its assets the company finances with borrowed funds.
How it is computed: (Liabilities + Accruals) / Assets - 71.43%
- Gross margin What it shows: The share of revenue left after the cost of goods, materials, energy and services.
How it is computed: Value added / Revenue - 7.59%
Financial statements as PDF
The files open in the Register of Financial Statements (RÚZ) in a new tab.
- Revenue
- €466,469
- Profit
- €1,702
- Assets
- €145,918
- Equity and liabilities
- €145,918
- Equity
- €41,900
- Debt ratio What it shows: How much of its assets the company finances with borrowed funds.
How it is computed: (Liabilities + Accruals) / Assets - 71.29%
- Gross margin What it shows: The share of revenue left after the cost of goods, materials, energy and services.
How it is computed: Value added / Revenue - 9.60%
Financial statements as PDF
The files open in the Register of Financial Statements (RÚZ) in a new tab.
- Revenue
- €480,623
- Profit
- €5,287
- Assets
- €133,638
- Equity and liabilities
- €133,638
- Equity
- €47,219
- Debt ratio What it shows: How much of its assets the company finances with borrowed funds.
How it is computed: (Liabilities + Accruals) / Assets - 64.67%
- Gross margin What it shows: The share of revenue left after the cost of goods, materials, energy and services.
How it is computed: Value added / Revenue - 13.82%
Financial statements as PDF
The files open in the Register of Financial Statements (RÚZ) in a new tab.
- Revenue
- €465,647
- Profit
- −€2,438
- Assets
- €135,879
- Equity and liabilities
- €135,879
- Equity
- €44,283
- Debt ratio What it shows: How much of its assets the company finances with borrowed funds.
How it is computed: (Liabilities + Accruals) / Assets - 67.41%
- Gross margin What it shows: The share of revenue left after the cost of goods, materials, energy and services.
How it is computed: Value added / Revenue - 11.42%
Financial statements as PDF
The files open in the Register of Financial Statements (RÚZ) in a new tab.
Assets
GEM - PHARM, spol. s r.o.
As of 31/12/2021
- €135,412 · 100.00%
As of 31/12/2022
- €140,714 · 100.00%
As of 31/12/2023
- €145,918 · 100.00%
As of 31/12/2024
- €133,638 · 100.00%
As of 31/12/2025
- €135,879 · 100.00%
Equity and liabilities
GEM - PHARM, spol. s r.o.
As of 31/12/2021
- €135,412 · 100.00%
As of 31/12/2022
- €140,714 · 100.00%
As of 31/12/2023
- €145,918 · 100.00%
As of 31/12/2024
- €133,638 · 100.00%
As of 31/12/2025
- €135,879 · 100.00%
Total income
GEM - PHARM, spol. s r.o.
| Year | Sales of goods, products and services | Other operating income | Interest income | Total |
|---|---|---|---|---|
| 2021 | €424,074 | €2,601 | €1 | €426,676 |
| 2022 | €506,738 | €1,807 | €1 | €508,546 |
| 2023 | €466,469 | €2,197 | €1 | €468,667 |
| 2024 | €480,623 | €148 | €3 | €480,774 |
| 2025 | €465,647 | €132 | €2 | €465,781 |
Costs
GEM - PHARM, spol. s r.o.
| Year | Cost of goods sold | Materials and energy | Services | Personnel costs | Depreciation | Other operating costs | Financial costs | Income tax | Total |
|---|---|---|---|---|---|---|---|---|---|
| 2021 | €353,486 | €7,962 | €26,746 | €28,735 | €1,714 | €2,918 | €2,812 | €626 | €424,999 |
| 2022 | €412,722 | €15,379 | €40,161 | €28,384 | €4,115 | €2,640 | €2,287 | €1,055 | €506,743 |
| 2023 | €378,058 | €10,596 | €33,054 | €34,221 | €4,115 | €2,787 | €3,093 | €1,041 | €466,965 |
| 2024 | €365,568 | €11,839 | €36,791 | €49,483 | €4,115 | €2,327 | €3,444 | €1,920 | €475,487 |
| 2025 | €366,338 | €9,791 | €36,354 | €43,700 | €2,400 | €4,072 | €3,644 | €1,920 | €468,219 |
Margins
GEM - PHARM, spol. s r.o.
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2021 | 8.46% | 1.21% | 0.40% |
| 2022 | 7.59% | 1.02% | 0.36% |
| 2023 | 9.60% | 1.25% | 0.36% |
| 2024 | 13.82% | 2.22% | 1.10% |
| 2025 | 11.42% | 0.67% | −0.52% |
Year-on-year change
GEM - PHARM, spol. s r.o.
| Year | Revenue | Profit |
|---|---|---|
| 2021 | −9% | 379% |
| 2022 | 20% | 8% |
| 2023 | −8% | −6% |
| 2024 | 3% | 211% |
| 2025 | −3% | −146% |
Financing structure
GEM - PHARM, spol. s r.o.
| Year | Equity | Provisions | Loans and assistance | Long-term liabilities | Short-term liabilities |
|---|---|---|---|---|---|
| 2021 | €38,394 | €6,413 | €10,389 | −€1,595 | €81,811 |
| 2022 | €40,198 | €1,484 | €0 | −€1,479 | €100,511 |
| 2023 | €41,900 | €1,904 | €17,135 | −€1,353 | €86,332 |
| 2024 | €47,219 | €1,719 | €18,620 | −€3,309 | €69,389 |
| 2025 | €44,283 | €2,528 | €24,032 | −€5,343 | €70,379 |
Income tax
GEM - PHARM, spol. s r.o.
| Year | Income tax | Current tax |
|---|---|---|
| 2021 | €626 | €626 |
| 2022 | €1,055 | €1,055 |
| 2023 | €1,041 | €1,041 |
| 2024 | €1,920 | €1,920 |
| 2025 | €1,920 | €1,920 |
Data sources
- Financial Administration of the Slovak Republic · updated 20/11/2026
- Register of Legal Entities (Statistical Office of the Slovak Republic, licence CC BY 4.0) · updated 20/11/2026
- OpenPeppol Directory · updated 20/11/2026
- Register of Financial Statements (RÚZ) · updated 20/11/2026
We take the data from the public registers as they publish it, unchanged and untranslated. FinPOST is an information website and does not verify the data. This page may be up to 7 days old. How we handle the data (privacy policy, section 3.9)